| Literature DB >> 35159487 |
Luís R Silva1,2, Telma A Jacinto1, Paula Coutinho1,2.
Abstract
Cardoon (Cynara cardunculus L.) is a Mediterranean plant and member of the Asteraceae family that includes three botanical taxa, the wild perennial cardoon (C. cardunculus L. var. sylvestris (Lamk) Fiori), globe artichoke (C. cardunculus L. var. scolymus L. Fiori), and domesticated cardoon (C. cardunculus L. var. altilis DC.). Cardoon has been widely used in the Mediterranean diet and folk medicine since ancient times. Today, cardoon is recognized as a plant with great industrial potential and is considered as a functional food, with important nutritional value, being an interesting source of bioactive compounds, such as phenolics, minerals, inulin, fiber, and sesquiterpene lactones. These bioactive compounds have been vastly described in the literature, exhibiting a wide range of beneficial effects, such as antimicrobial, anti-inflammatory, anticancer, antioxidant, lipid-lowering, cytotoxic, antidiabetic, antihemorrhoidal, cardiotonic, and choleretic activity. In this review, an overview of the cardoon nutritional and phytochemical composition, as well as its biological potential, is provided, highlighting the main therapeutic effects of the different parts of the cardoon plant on metabolic disorders, specifically associated with hepatoprotective, hypolipidemic, and antidiabetic activity.Entities:
Keywords: Cynara cardunculus L.; Mediterranean plant; biological activities; metabolic disorders; phytochemical composition
Year: 2022 PMID: 35159487 PMCID: PMC8915173 DOI: 10.3390/foods11030336
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Nutritional composition of raw cardoon [48].
| Nutrient (Unit) | Raw |
|---|---|
| Basic chemical composition | |
| Water (g/100 g) | 94 |
| Energy (kcal/100 g) | 17 |
| Energy (kJ/100 g) | 71 |
| Macronutrients | |
| Total protein (g/100 g) | 0.7 |
| Total lipids (g/100 g) | 0.1 |
| Fatty acids, total saturated (g/100 g) | 0.011 |
| SFA 16:0 (g/100 g) | 0.009 |
| SFA 18:0 (g/100 g) | 0.002 |
| Fatty acids, total monounsaturated (g/100 g) | 0.018 |
| MUFA 16:1 (g/100 g) | 0 |
| MUFA 18:1 (g/100 g) | 0.018 |
| MUFA 20:1 (g/100 g) | 0 |
| Fatty acids, total polyunsaturated (g/100 g) | 0.041 |
| PUFA 18:2 (g/100 g) | 0.041 |
| Carbohydrates (g/100 g) (by difference) | 4.07 |
| Total ash (g/100 g) | 1.13 |
| Total dietary fiber (g/100 g) | 1.6 |
| Total sugars (g/100 g) | 4.07 |
| Micronutrients | |
| Minerals | |
| Calcium, Ca (mg/100 g) | 70 |
| Iron, Fe (mg/100 g) | 0.7 |
| Magnesium, Mg (mg/100 g) | 42 |
| Phosphorus, P (mg/100 g) | 23 |
| Potassium, K (mg/100 g) | 400 |
| Sodium, Na (mg/100 g) | 170 |
| Zinc, Zn (mg/100 g) | 0.17 |
| Cooper, Cu (mg/100 g) | 0.23 |
| Manganese, Mn (mg/100 g) | 0.256 |
| Fluoride, F (µg/100 g) | 0.2 |
| Vitamins | |
| Vitamin C (mg/100 g) | 2 |
| Thiamin (mg/100 g) | 0.02 |
| Riboflavin (mg/100 g) | 0.03 |
| Niacin (mg/100 g) | 0.3 |
| Pantothenic acid (mg/100 g) | 0.338 |
| Vitamin B6 (mg/100 g) | 0.116 |
| Folate, total (µg/100 g) | 68 |
| Folate, DFE (µg/100 g) | 68 |
| Folate, food (µg/100 g) | 68 |
| Vitamin A, RAE (µg/100 g) | 0 |
| Vitamin A, IU (IU/100 g) | 0 |
| Vitamin B12 (µg/100 g) | 0 |
| Vitamin D (D2 + D3) IU (IU/100 g) | 0 |
| Vitamin D (D2 + D3) (µg/100 g) | 0 |
Free sugar composition of cardoon vegetal parts.
| Free Sugars | Raw A | Roots B | Flowers C | Seeds D | Bracts E | Heads F |
|---|---|---|---|---|---|---|
| Fructose | - | 0.1–6.47 | - | n.d.–1.94 | 0.14–1.41 | 0.013–0.51 |
| Glucose | - | 0.07–4.54 | 2.47–4.69 | n.d.–0.78 | 0.10–0.557 | 0.0–2.02 |
| Sucrose | - | 0.16–4.39 | - | 0.30–8.77 | 0.12–4.970 | n.d.–2.39 |
| Trehalose | - | - | - | 0.16–36.44 | 0.24–1.16 | 0.23–0.98 |
| Raffinose | - | - | - | n.d-1.31 | n.d.–2.13 | 0.0–2.62 |
| Rhamnose | 0.75–1.1 | - | 1.10–1.19 | - | - | - |
| Arabinose | 1.17–2.7 | - | 4.23–6.03 | - | - | - |
| Xylose | 21.49–27.0 | - | 2.12–2.61 | - | - | - |
| Mannose | 1.1–1.8 | - | 0.44–0.52 | - | - | - |
| Galactose | 1.35–2.5 | - | 1.27–1.82 | - | - | - |
| Inulin | - | 22.4–49.6 * | - | - | - | - |
n.d., not detected; * values for roots with 2 years; -, there are no data. A [58,59]; B [32,39]; C [45]; D [7,46,47]; E [43]; F [7].
Fiber composition of cardoon vegetal parts.
| Fiber (g/100 g d.w.) | Raw A | Stems B | Stalks C | Leaves D | Flowers E |
|---|---|---|---|---|---|
| Hemicellulose | 12.8–18.19 | 18.7–19.1 | 47.3–55.2 | 4.6–11.3 | 16.30–17.16 |
| Cellulose | 30.52–41.9 | 50.4–51.7 | 17.9–27.0 | 29.0–34.3 | 10.33–17.73 |
| Lignin | 14.21–18.9 | 10.7–11.9 | 13.3–28.8 | 8.7–12.5 | 7.60–10.73 |
A [58,60]; B [35]; C [10,59,62,63]; D [35]; E [45].
Fatty-acid composition of cardoon vegetal parts.
| Fatty Acid | Raw A | Flowers B | Seeds C | Bracts D | Heads E |
|---|---|---|---|---|---|
| C6:0 | n.d.–0.40 | 0.019–16.3 | 0.0094–0.05 | 0.082–3.710 | |
| C8:0 | - | 0.014–3.0 | 0.0086–0.0429 | 0.057–1.314 | |
| C10:0 | - | 0.015–0.151 | 0.00122–0.044 | 0.186–0.473 | |
| C11:0 | 0.85–1.98 | 0.027–0.67 | 0.025–0.092 | 0.16–0.579 | |
| C12:0 | - | 0.015–0.18 | 0.0073–0.2502 | 0.326–2.57 | |
| C13:0 | 1.05–1.17 | - | n.d.–0.0105 | 0.0–0.084 | |
| C14:0 | 0.11 | 1.08–1.15 | 0.103–0.59 | 0.037–0.335 | 0.58–2.69 |
| C14:1 | - | - | n.d.–0.0083 | 0.0–0.54 | |
| C15:0 | - | 0.032–0.125 | 0.016–0.092 | 0.0–0.48 | |
| C15:1 | - | - | 0.0026–1.5197 | 0.0–1.36 | |
| C16:0 | 0.009–10.8 | 40.87–45.45 | 11–55.948 | 0.0367–6.183 | 14.62–43.8 |
| C16:1 | n.d.–0.02 | n.d.–1.46 | 0.02–0.78 | 0.0076–0.039 | 0.317–12.76 |
| C17:0 | 0.06 | - | 0.062–0.33 | 0.0184–0.0915 | 0.313–0.779 |
| C18:0 | 0.002–3.6 | 4.83–6.28 | 3.289–16.39 | 0.209–1.775 | 2.687–6.0 |
| C18:1 | 0.018–27.3 | 2.09–3.33 | 0.58–3.77 | 0.195–0.903 | 4.48–46.6 |
| C18:2 | 0.041–56.8 | 25.10–29.91 | 1.7–83.3 | 0.054–2.208 | 0.748–30.6 |
| C18:3 | 0.17 | 3.67–7.12 | 60.15–70.41 | - | 0.0–0.176 |
| C18:3 | - | 0.037–4.060 | 0.0076–0.543 | 0.3675–7.5 | |
| C20:0 | 0.37 | 3.10–3.76 | 0.112–1.8 | 0.0049–0.3693 | 0.377–3.225 |
| C20:1 | 0 | - | 0.08–0.49 | 0.0042–0.032 | 0.0–4.52 |
| C20:2 | - | 0.18–0.24 | n.d.–0.022 | 0.0–0.31 | |
| C21:0 | - | 0.064–0.079 | n.d.–0.07 | 0.070–0.324 | |
| C20:3 | - | 0.012–0.015 | n.d.–0.1018 | 0.0–8.6 | |
| C20:3 | - | - | n.d.–0.156 | 0.0–1.38 | |
| C22:0 | 0.12 | - | - | 0.063–0.447 | 0.0–2.6365 |
| C22:1 | 0.15 | - | 0.103–0.19 | 0.0036–0.032 | 0.12–4.9505 |
| C20:5 | - | - | 0.0039–0.06 | 0.0–0.6285 | |
| C22:2 | 1.58–2.88 | - | n.d.–0.669 | 0.0–0.30 | |
| C23:0 | 1.32–1.77 | 0.17–1.51 | n.d.–0.06 | 0.26–1.61 | |
| C24:0 | 0.19 | - | 0.199–0.66 | n.d.–0.128 | 0.0–7.411 |
| Total variation | |||||
| SFA | 0.861–15.27 | 57.07–64.99 | 15.5–95.5 | 1.074–9.167 | 22.9–61.9 |
| MUFA | 0.168–27.47 | 3.33–3.55 | 0.84–19.39 | 0.242–2.034 | 5.61–52.1 |
| PUFA | 0.211–56.8 | 31.66–38.61 | 1.9–83.7 | 0.076–2.955 | 1.895–47.7 |
Fatty acids are expressed as a relative percentage of each fatty acid. n.d.—not detected; C6:0—caproic acid; C8:0—caprylic acid; C10:0—capric acid; C11:0—undecanoic acid; C12:0—lauric acid; C13:0—tridecanoic acid; C14:0—myristic acid; C14:1—tetradecanoic acid; C15:0—pentadecanoic acid; C15:1—pentadecanoic acid; C16:0—palmitic acid; C16:1—palmitoleic acid; C17:0—heptadecanoic acid; C18:0—stearic acid; C18:1n9—oleic acid; C18:2n6c—linoleic acid; C18:3n6-gamma-linolenic acid; C18:3n3—alpha-linolenic acid; C20:0—arachidic acid; C20:1—gondoic acid; C20:2—eicosadienoic acid; C21:0—heneicosanoic acid; C20:3n6—eicosatrienoic acid; C20:3n3—11,14,17-eicosatrienoic acid; C22:0—behenic acid; C22:1—erucic acid; C20:5n3—eicosapentaenoic acid; C22:2—docosadienoic acid; C23:0—tricosanoic acid; C24:0—lignoceric acid; SFA—saturated fatty acid; MUFA—monounsaturated fatty acid; PUFA—polyunsaturated fatty acid; n-6/n-3: ratio of omega 6/omega 3 fatty acids. -, There is no data. A [48,61]; B [45]; C [7,46,47]; D [43]; E [7].
Phytosterol and tocopherol composition of cardoon vegetal parts.
| Tocopherols | Stalks A | Leaves B | Flowers C | Seeds D | Bracts and | Heads F |
|---|---|---|---|---|---|---|
| n.d. | 39.9–100.7 | n.d. | 1.210–29.620 | n.d.–0.062 | 0.25–0.619 | |
| - | - | - | n.d. | n.d.–0.120 | n.d. | |
| Cholesterol | 1.0–1.3 | 27.6 | - | - | n.d. | - |
| 24-Methylenecholesterol | 0.7–1.7 | n.d.-19.3 | - | 5.4–6.5 | n.d. | - |
| Campesterol | 2.6–5.6 | 15.1–24.8 | - | 15.0–17.0 | 8.1–11.7 | - |
| Stigmasterol | 12.9–32.4 | 33.8–58.8 | 45.9–46.1 | - | 52.3–54.2 | - |
| 13.1–25.7 | 63.9–171.6 | 49.8–70.8 | - | 39.2–63.7 | - | |
| 2.5–4.0 | n.d. | n.d. | - | nd-10.6 | - | |
| Δ5-Avenasterol | n.d. | 20.0–32.5 | 23.9–28.0 | - | n.d. | - |
n.d., not detected; -, there are no data. A [44];B [44]; C [44]; D [46,47];E [43,44]; F [7].
Organic acids composition of cardoon vegetal parts.
| Organic Acid | Seeds A | Bracts B | Heads C |
|---|---|---|---|
| Oxalic | 0.079–0.304 | 0.093–9.5 | 0.324–12.1 |
| Quinic | tr–0.07 | tr–4.82 | 0.017–3.3 |
| Malic | tr–0.086 | tr–1.87 | n.d.–2.31 |
| Citric | n.d.–0.33 | n.d.–1.9 | n.d.–0.86 |
| Fumaric | tr | n.d.–0.0076 | n.d.–0.0542 |
| Total variation | 0.03–6.54 | 1.96–15.6 | 0.89–15.7 |
d.w., dry weight; tr, traces; n.d., not detected. A [46,47]; B [43]; C [7].
Mineral composition of cardoon vegetal parts.
| Minerals (mg/100 g d.w.) | Raw A | Flowers B | Seeds C |
|---|---|---|---|
| K | 400 | 1600–1710 | 493–880 |
| Na | 170 | 200–300 | 12–24 |
| Ca | 70 | 580–1010 | 734–1583 |
| Mg | 42 | 150–170 | 241–809 |
| Mn | 0.256 | - | 4.21–6.2 |
| Fe | 0.7 | - | 9.2–16 |
| Zn | 0.17 | - | 1.4–5.2 |
-, there are no data. A [48]; B [45]; C [47].
Vitamin content of raw cardoon and raw artichoke.
| Vitamins | Cardoon Raw | Artichoke Raw |
|---|---|---|
| Vitamin C (mg) | 2.0 | 11.7 |
| Thiamin (mg) | 0.02 | 0.07 |
| Riboflavin (mg) | 0.03 | 0.07 |
| Niacin (mg) | 0.3 | 0.9 |
| Pantothenic acid (mg) | 0.338 | 0.34 |
| Vitamin B6 (mg) | 0.116 | 0.12 |
| Total folate (µg) | 68.0 | 68.0 |
| Vitamin A µg) | 0 | 8.0 |
| Vitamin E (mg) | - | 0.19 |
Data adapted from [48]. -, There is no data.
Volatile organic compounds found in vegetal parts of cardoon.
| Volatile Organic Compounds | Vegetal Parts | References |
|---|---|---|
| Aromatic compounds | ||
| Benzoic acid | Stalks, receptacles and bracts, florets, leaves | [ |
| Vanillin | Stalks, receptacles and bracts, leaves | [ |
| Syringaldehyde | Stalks, receptacles and bracts, florets, leaves | [ |
| 2,6-Dimethoxyhydroquinone | Stalks, receptacle and bracts, florets | [ |
| 3-Vanillylpropanol | Stalks, florets, leaves | [ |
| Vanillylpropanoic acid | Florets | [ |
| Scopolin | Florets | [ |
| Benzaldehyde | Stalks, leaves | [ |
| Furfural | Leaves | [ |
| ( | Leaves | [ |
| 1-Octen-3-one | Leaves | [ |
| 6-Methyl-5-hepten-2-one | Leaves | [ |
| Octanal | Leaves | [ |
| Benzene acetaldehyde | Leaves | [ |
| ( | Leaves | [ |
| Acethophenone | Leaves | [ |
| ( | Leaves | [ |
| Leaves | [ | |
| ( | Leaves | [ |
| Phenetyl alcohol | Leaves | [ |
| Isophorone | Leaves | [ |
| 3-Nonen-2-one | Leaves | [ |
| ( | Leaves | [ |
| Leaves | [ | |
| Safranal | Leaves | [ |
| Decanal | Leaves | [ |
| Leaves | [ | |
| Neral | Leaves | [ |
| | Leaves | [ |
| Geranial | Leaves | [ |
| | Leaves | [ |
| Eugenol | Leaves | [ |
| | Leaves | [ |
| ( | Leaves | [ |
| Geranyl acetone | Leaves | [ |
| | Leaves | [ |
| Dicyclohexyl-methanone | Leaves | [ |
| Dihydroactinidiolide | Leaves | [ |
| Phytone | Leaves | [ |
| Fatty acids | ||
| Saturated | [ | |
| Tetradecanoic acid | Stalks, receptacle and bracts, florets, leaves | [ |
| Pentadecanoic acid | Stalks, receptacle and bracts, florets, leaves | [ |
| Hexadecanoic acid | Stalks, receptacle and bracts, florets, leaves | [ |
| Heptadecanoic acid | Stalks, receptacle and bracts, florets, leaves | [ |
| Octadecanoic acid | Stalks, receptacle and bracts, florets, leaves | [ |
| Nonadecanoic acid | Stalks, receptacle and bracts, florets, leaves | [ |
| Eicosanoic acid | Stalks, receptacle and bracts, florets, leaves | [ |
| Heneicosanoic acid | Stalks, receptacle and bracts, florets, leaves | [ |
| Docosanoic acid | Stalks, receptacle and bracts, florets, leaves | [ |
| Tricosanoic acid | Stalks, receptacle and bracts, florets, leaves | [ |
| Tetracosanoic acid | Stalks, receptacle and bracts, florets, leaves | [ |
| Pentacosanoic acid | Stalks, receptacle and bracts, florets | [ |
| Hexacosanoic acid | Stalks, florets, leaves | [ |
| Octacosanoic acid | Stalks, florets, leaves | [ |
| Unsaturated | ||
| | Stalks, receptacle and bracts, florets, leaves | [ |
| | Stalks, receptacle and bracts, florets, leaves | [ |
| 9,12-Octadecadienoic acid | Stalks, receptacle and bracts, florets, leaves | [ |
| 9,12,15-Octadecatrienoic acid | Stalks, receptacle and bracts, florets, leaves | [ |
| | Stalks, receptacle and bracts, florets | [ |
| | Stalks, receptacle and bracts, florets | [ |
| Hydroxy fatty acids | Stalks, florets | [ |
| 2-Hydroxyheptanoic acid | Stalks | [ |
| 2-Hydroxyundecanoic acid | Florets | [ |
| Long-chain aliphatic alcohols | ||
| Hexadecanol-1-ol | Stalks, receptacle and bracts, florets, leaves | [ |
| | Stalks, receptacle and bracts, florets | [ |
| Octadecan-1-ol | Stalks, receptacle and bracts, florets, leaves | [ |
| Eicosan-1-ol | Stalks, receptacle and bracts, florets | [ |
| Docosan-1-ol | Stalks, receptacle and bracts, florets, leaves | [ |
| Tetracosan-1-ol | Stalks, receptacle and bracts, florets, leaves | [ |
| Hexacosan-1-ol | Stalks, receptacle and bracts, florets, leaves | [ |
| Octocosan-1-ol | Stalks, florets, leaves | [ |
| Sesquiterpene lactones | ||
| Grosheimin | Stalks, leaves | [ |
| Deacylcynaropicrin | Stalks, receptacle and bracts, leaves | [ |
| Cynaropicrin | Stalks, receptacle and bracts, leaves | [ |
| Pentacyclic triterpenes | ||
| | Stalks, receptacle and bracts, florets, leaves | [ |
| | Stalks, receptacle and bracts, florets, leaves | [ |
| | Stalks, receptacle and bracts, florets, leaves | [ |
| | Stalks, receptacle and bracts, florets, leaves | [ |
| Lupenyl acetate | Stalks, receptacle and bracts, florets, leaves | [ |
| | Stalks, receptacle and bracts, florets, leaves | [ |
| Taraxasterol | Stalks, receptacle and bracts, florets, leaves | [ |
| | Stalks, receptacle and bracts, florets, leaves | [ |
| Taraxasteryl acetate | Stalks, receptacle and bracts, florets, leaves | [ |
| Others | ||
| Inositol | Stalks, receptacle and bracts, florets, leaves | [ |
| 2,3-Dihydroxypropyl hexadecanoate | Stalks, receptacle and bracts, florets, leaves | [ |
| | Leaves | [ |
Phenolic compounds found in vegetal parts of cardoon.
| Phenolic Compounds | Vegetal Parts | References |
|---|---|---|
| 1- | Leaves (n.d.–0.3 mg/g d.w.) | [ |
| 3- | Leaves (n.d.–tr mg/g d.w.) | [ |
| Seeds (0.96–35.8 mg/g d.w.) | [ | |
| 5- | Stalks (2.30–3.15 mg/g d.w.) | [ |
| Seeds (n.d.–0.777 mg/g d.w.) | [ | |
| 1,3- | Stalks (tr mg/g d.w.) | [ |
| 3,4- | Seeds (0.507–6.2 mg/g d.w.) | [ |
| 3,5- | Seeds (14.8–418 mg/g d.w.) | [ |
| 1,4-Dicaffeoylquinic acid | Stalks (tr–0.68 mg/g d.w.) | [ |
| 1,5-Dicaffeoylquinic acid | Stalks (tr–1.09 mg/g d.w.) | [ |
| 4,5-Dicaffeoylquinic acid | Stalks (n.d.–tr mg/g d.w.) | [ |
| 4-Acyl-di- | Leaves (n.d.) | [ |
| Tri- | Heads (n.d.–1.29 mg/g d.w.) | [ |
| Dicaffeoylquinic acids | Leaves (9.44–51.15 µmol/g d.w.) | [ |
| Bracts (n.d.–1.4 mg/g d.w.) | [ | |
| Heads (n.d.–3.55 mg/g d.w.) | [ | |
| Succinyl-diCQA I | Stalks (n.d.–tr) | [ |
| Succinyl-diCQA II | Stalks (n.d.) | [ |
| Succinyl-diCQA III | Stalks (n.d.) | [ |
| Succinyl-dicaffeoylquinic acid | Leaves (n.d.–8.67 µmol/g d.w.) | [ |
| 1,5-Di- | Leaves (n.d.) | [ |
| 4-Acyl-di- | Leaves (n.d.) | [ |
| Dicaffeoylsuccinoylquinic acid isomer | Leaves (n.d.) | [ |
| Dicaffeoyldisuccinoylquinic acid isomer | Leaves (n.d.) | [ |
| Eridictyol- | Bracts (n.d.–0.98 mg/g d.w.) | [ |
| Eriodictyol hexoside | Leaves (n.d.) | [ |
| Leaves extracts (0.09–1.1 mg/g d.w.) | [ | |
| 5- | Bracts (n.d.–0.55 mg/g d.w.) | [ |
| Scopolin isomer | Leaves (n.d.) | [ |
| Kaempferol-3- | Bracts (n.d.–0.59 mg/g d.w.) | [ |
| Luteolin- | Bracts (n.d.–2.036 mg/g d.w.) | [ |
| Luteolin-7- | Heads (n.d.–0.90 mg/g d.w.) | [ |
| Luteolin- | Bracts (n.d.–1.51 mg/g d.w.) | [ |
| Luteolin acetyl-hexoside | Leaves (0.7 mg/g d.w.) | [ |
| Luteolin-7- | Leaves (n.d.–6.5 mg/g d.w.) | [ |
| Luteolin glucoside | Leaves (n.d.–4.2 mg/g d.w.) | [ |
| Luteolin-7- | Leaves (0.66–33.55 µmol/g d.w.) | [ |
| Luteolin- | Bracts (n.d.–1.265 mg/g d.w.) | [ |
| Luteolin-7- | Leaves (1.11–43.00 µmol/g d.w.) | [ |
| Luteolin | Leaves (0.02–2.02 µmol/g d.w.) | [ |
| Apigenin-7- | Bracts (2.79–10.6 mg/g d.w.) | [ |
| Apigenin glucuronide | Leaves (2.9 mg/g d.w.) | [ |
| Apigenin-7- | Heads (n.d.–1.07 mg/g d.w.) | [ |
| Apigenin | Leaves (n.d.–6.79 µmol/g d.w.) | [ |
| Apigenin- | Bracts (n.d.–1.77 mg/g d.w.) | [ |
| Apigenin acetyl-hexoside | Leaves (0.5 mg/g d.w.) | [ |
| Apigenin-7- | Heads (0.99–3.51 mg/g d.w.) | [ |
| Apigenin-7- | Leaves (n.d.–0.1 mg/g d.w.) | [ |
| Apigenin-malonylhexoside | Heads (n.d.–1.17 mg/g d.w.) | [ |
| Naringenin-7- | Leaves (n.d.) | [ |
| Naringenin rutinoside | Leaves (n.d.) | [ |
| Naringenin | Leaves (n.d.) | [ |
| Chrysoeriol hexoside isomer | Leaves (0.5 mg/g d.w.) | [ |
| Chrysoeriol isomer | Leaves (n.d.) | [ |
tr, traces (below the limit of quantification); n.d., not detected.
Overview of the hepatoprotective activity of Cynara Cardunculus.
| Plant Variety | Intervention | Study Type | Model | Results | Ref. |
|---|---|---|---|---|---|
| var. | Aqueous infusion of flower heads |
| CCl4-induced damage in HepG2 cells | The aqueous infusion of separate flower heads of | [ |
| Ethanol extract from leaves |
| Wistar Rats with high-fat diet (HFD)-induced obesity | The administration of artichoke extract caused a decrease in pancreatic lipase compared to the HFD group and reduced organ weight. In addition, the serum lipid profile and the values of the hepatic enzymes were restored. | [ | |
| Hydroethanolic |
| Wistar Rats with phenylhydrazine-induced hemolytic anemia | The groups treated with | [ | |
| Ethanolic extracts from artichoke (plant part) |
| ICR mice with acute alcohol-induced liver injury | The pretreatment with 1.6 g/kg BW of artichoke had a preventive effect due to its ability to reduce the lipidic profile and MDA while increasing SOD and GSH, as well as the inhibition of the inflammatory pathway by suppressing the expression levels of TLR4 and NF- | [ | |
| Methanol extract from leaves |
| Mice infected with | Upon treatment with ALE either alone or in conjugation with praziquantel, there was an improvement of the liver enzymes. In addition, ALE-treated groups exhibited a reduction in the granuloma size due to the increase in hepatic stellate cell recruitment, ultimately improving liver fibrosis. | [ | |
| Aqueous leaf extract |
| High-fat and high-cholesterol diet-induced steatohepatitis and liver damage in mice | After ALE treatment, there was a reduction of the hepatic triglyceride level and inflammation, as well as a suppression of the liver damage induced by high-fat and high-cholesterol diet in mice. | [ | |
| var. | Ethanol extract from receptacle, stem, inner bract, outer bract, and leaves |
| Sprague–Dawley rats with paracetamol-induced hepatotoxicity and nephrotoxicity | There were no significant changes in ALT and AST levels after the treatment with the different parts from artichoke; however, the histopathological data showed that the receptacle and stem extracts of | [ |
| var | Aqueous extract from heads and leaves |
| Sprague–Dawley rats with diethylnitrosamine (DEN)-induced hepatocellular carcinoma | The treatment with fish oil 10% or 1 g of artichoke leaves led to better improvement of DEN-induced changes in the biochemical parameters, such as antioxidant enzymes, angiogenic growth factors, liver function enzymes, and other substances produced by the liver. | [ |
| Ethanol extract from leaves |
| Albino mice of C57BL/6 with acetaminophen-induced hepatotoxicity | After the treatment with ALE, silymarin, or their conjugation, there was an improvement of the serum liver enzymes, a decrease in MDA levels, an increase in glutathione reductase, and a decrease in PCNA expression. Thus, both plant extracts had hepatoprotective activity against acetaminophen. | [ | |
| Hydroethanolic extract from leaves |
| Wistar rats with acutediazinon-induced liver injury | The treatment with ALE caused a reduction in serum ALP, AST, ALT, MDA, TNF- | [ | |
| Aqueous extract from leaves |
| Sprague–Dawley rats with paracetamol-induced hepatotoxicity | Pretreatment with ALE (1.5 g/kg) reduced ALT and AST levels. In addition, the hepatic lipid peroxidation and NO levels also exhibited a reduction, whereas SOD and antioxidant enzymes activity increased. Furthermore, the pretreated group presented a reduction in DNA damage. | [ | |
| Ethanol extract from leaves |
| Wistar Rats with cadmium (Cd) toxicity-induced oxidative organ damage | The ALE-treated rats exhibited a significant reduction in the oxidative stress in the Cd-exposed rats. Furthermore, ALE alone increased the GSH and CAT activity levels in rat liver and reduced liver lesions. | [ | |
| var. | Ethanol extract from leaves |
| Sprague–Dawley rats with carbon tetrachloride-induced oxidative stress and hepatic injury | After treating rats with ALE, the levels of AST and ALT were decreased by 40% and 52%, respectively, in the curative group compared to the CCl4 group, normalized to the antioxidant system, due to the decrease in SOD and MDA levels. | [ |
| Luteolin-enriched artichoke leaves |
| C57BL/6N mice with HFD-induced obesity | Luteolin-enriched artichoke leaves and luteolin treatments significantly decreased the hepatic PAP enzyme activity and increased the activity of hepatic CPT. | [ | |
| Hydroethanolic extract of artichoke |
| Wistar rats with lead acetate-induced toxicity | Upon the treatment with the ALE, there was a decrease in the lipid profile levels and lead serum levels. | [ | |
| var. | Aqueous extract from leaves |
| Rats with 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis | After treating the mice with the extract, there was no significant variation in the ALT values comparing with the TNBS-treated mice. | [ |
| Butanolic extract from aerial parts |
| Male albino rats with paracetamol induced liver injury | After 10 days, rats pretreated with the extract (300 mg/kg) prevented the increase in AST, ALT, and ALP caused by paracetamol. | [ | |
| var | Hydroethanolic |
| Liver damage induced by deltamethrin in weanling male rats | After 28 days of supplementation with an herbal syrup (sucrose, extract from C. | [ |
| var | Leaves extract encapsulated in capsules | Clinical trial | Adult patients with a history of at least 12 months of T2DM and NAFLD | After 16 weeks, the patients supplemented with C. | [ |
| var. | Cynarol® (Leaves extract) | Clinical trial | Subjects with nonalcoholic fatty liver disease | After the treatment with ALE the hepatic vein flow increased, and portal vein diameter and liver size decreased when compared with placebo. Furthermore, the treatment also reduced both AST and ALT, as well as traditional liver markers and serum lipid profile. | [ |
| - | Clinical trial | Patients with nonalcoholic steatohepatitis | After the treatment with | [ |
-, there are no data.
Overview of the hypolipidemic activity of Cynara cardunculus.
| Variety/Species | Intervention | Study Type | Model | Result | Ref. |
|---|---|---|---|---|---|
| var. | Ethanol extract from Leaves |
| HFD-induced cellular obesity and cardiac damage in Wistar Rats | Oral administration of ALE at two doses 200 and 400 mg/kg decreased lipase pancreatic activity, improved the lipid profile, significantly decreased the cardiac markers, and improved the antioxidant activity and oxidative stress markers. | [ |
| Ethanol extract from leaves |
| HFD-induced obesity in Wistar rats | After the treatment, there was a normalization of serum lipid profile, a decrease in urea, uric acid, and creatinine, a reduction in the formation of lipid accumulation and AOPP, and an increment in the antioxidant activity. | [ | |
| Aqueous extract from Leaves |
| Golden Syrian hamsters | After 42 days, the ALE fed hamsters exhibited a decrease in TC, non-HDL, and TG. In addition, there was an increase in the excretion of bile acids and neutral sterols. | [ | |
| Aqueous extract from Leaves |
| Wistar rats fed on high-cholesterol diet | The rats fed on high-cholesterol diet treated with ALE exhibited a decrease in the serum lipidic profile. | [ | |
| Extract from Leaves |
| C57BL/6N mice with HFD-Induced Obesity | When treated with ALE and luteolin-enriched ALE, there was a decrease in the plasma, hepatic, and fecal lipid profile, as well as a decrease in the hepatic PAP enzyme activity. | [ | |
| var. | Hydroalcoholic extract from leaves |
| Insulin resistance, hyperlipidemia, and NAFLD in Sprague–Dawley rats fed a hyperlipidemic diet | After the treatment with ALE, the rats on a high-fat diet exhibited a decrease in the serum lipid profile in a dose-dependent manner. | [ |
| var. | Ethanol extract from leaf |
| DNA damage and atherosclerosis in Wistar albino rats fed an atherogenic diet | TG and HDL-c showed a significant decrease in the ALE-treated rats, when compared to the control group. | [ |
| var. | Aqueous extract from leaves |
| Hepatic and cardiac oxidative stress in Wistar rats fed on high-cholesterol diet | Hypercholesterolemic rats treated with ALE exhibited a decrease in the serum TC and TG levels; however, in the liver, there was no change. On the other hand, this treatment reduced the MDA and diene conjugate levels in the liver and heart tissues, and there was an increase in hepatic vitamin E levels and GSH-Px activities. | [ |
| Aqueous extract from leaves and aqueous extract from stems |
| Rats fed with HFD and vitamin C supplement | Both extracts reduced the lipid profile levels, as well as GOT and GTP values. | [ | |
| Red yeast rice extract, policosanol, and var. | Limicol® (w/200 mg of | Wistar rats and subjects with untreated hypercholesterolemia | After 4 weeks of supplementation, LDL-c and TC were significantly lower in the supplemented group than in the placebo. | [ | |
| var. | Hydroalcoholic extract from leaves | Clinical trial | Women with metabolic syndrome | After 12 weeks of treatment with ALE, the carriers of A allele of FTO-rs9939609 exhibited a significant decrease in serum TG level compared with the controls. However, there was no genotype–intervention interaction for the TCF7L2-rs7903146 polymorphism. | [ |
| Red yeast rice extract, policosanol and var. | Limicol® (w/200 mg of | Clinical trial | Subjects with moderate hypercholesterolemia | LDL-c and TC were reduced by, respectively, 21.4% and 14.1% at week 16 in the supplemented group compared with baseline. Furthermore, triglyceride levels decreased by 12.2% after 16 weeks in the supplemented group. | [ |
| Subjects with moderate untreated hypercholesterolemia | The group treated with a supplement of red yeast rice, policosanols, and artichoke leaf extracts exhibited a significant decrease in LDL-c, TC, and apo B in healthy subjects with moderate hypercholesterolemia. On the other hand, no effect was demonstrated on other lipid concentrations, and there was no alteration in liver and renal function markers and in the muscle breakdown. | [ | |||
| var. | Extract from leaves | Clinical trial | Patients with nonalcoholic steatohepatitis | After the treatment with ALE, the AST and ALT levels decreased, as well as the TG and TC levels. | [ |
| Extract from leaves | Clinical trial | Subjects with primary mild hypercholesterolemia | The supplemented group exhibited a significant decrease in TC, LDL-c, and LDL/HDL compared with the placebo. Furthermore, the supplementation caused an increase in HDL-c, which might have clinical interest owing to its protective role in cardiovascular disease. | [ |
Overview of the antidiabetic activity of Cynara cardunculus.
| Variety/Species | Intervention | Study Type | Model | Result | Ref. |
|---|---|---|---|---|---|
| var. | Ethanolic and aqueous extract from outer bracts and the stems |
| - | Both ethanolic and aqueous extracts were capable of inhibiting fructosamine formation and antiglycative agents. Moreover, the aqueous extract had a better performance against the systems containing glucose and fructose; on the contrary, the ethanolic extract demonstrated a better activity to inhibit AGE formation when ribose or MGO acted as precursors. | [ |
| Methanolic extract from inedible floral stems | Suisse albino mice with alloxan-induced diabetes | The administration of the extract resulted in a decrease in the serum profile levels and blood glucose. | [ | ||
| var. | Aqueous extract | Wistar rats with STZ-induced diabetes | Both plant extracts presented good anti-glucosidase, antiglycation, and antihyperglycemic properties. In addition, the experiments on isolated aortas exhibited an improvement of vascular dilatory functions in diabetic animals. | [ | |
| var | Ethanolic extract from leaves | Wistar rats with alloxan-induced diabetes | Both doses of the extract from | [ | |
| Methanol extract of cereal-based chips enriched with omega-3-rich fish oil and artichoke bracts | Suisse Albino mice with alloxan-induced diabetes | In diabetic mice, the enriched chips normalized the levels of blood glucose and serum markers such as alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, urea, and creatinine. Furthermore, there was an improvement of the serum lipid profile. | [ | ||
| Butanolic extract from leaves |
| Albino rats with streptozotocin (STZ)-induced hyperglycemia | The treatment caused a decrease in the blood sugar levels in the diabetes induced-rats, compared with the STZ diabetic rats. | [ | |
| Hydroalcoholic extract from leaves |
| Wistar rats with STZ-induced diabetes | In the groups with the administration of artichoke extract, compared with the diabetic group, there was an increase in insulin levels, while the serum concentrations of glucagon and glucose were reduced. | [ | |
| var. | Ethanolic extract |
| Wistar rats with STZ-induced diabetes | When compared with glibenclamide, the use of artichoke extract decreased the lipid profile, increased HLD-c, and decreased HbA1C. However, compared with the group treated with glibenclamide, fasting blood glucose levels were elevated. | [ |
| var. | Aqueous extract from leaves |
| Sprague–Dawley albino rats with induced hypercholesterolemia | The hypercholesterolemia-induced rats treated with both doses of ALE exhibited a decrease in fasting blood glucose, creatinine, uric acid, and urea. These results show that artichoke extracts can be used as a complementary treatment for renal damage and diabetes. | [ |
| var | Hydroalcoholic extract from flowering head |
| Wistar rats and obese Zucker rats | [ | |
| Luteolin-enriched artichoke leaves |
| C57BL/6N mice with high-fatdiet-induced obesity | The treatment with ALE and luteolin-enriched ALE reduced the levels of insulin and glucose. | [ | |
| Hydroalcoholic extract from flowering head |
| Wistar rats | The combination of both plants extract resulted in a reduction in the food intake, mainly due to the | [ | |
| var | Hydroalcoholic extract from leaves |
| Sprague–Dawley rats with nonalcoholic fatty liver disease induced by high-fat diet | The administration of the extract in a high-fat diet reduced the levels of serum glucose, serum lipid profile, and MDA. Moreover, the 20 mg/kg dose was more effective in completely and significantly restoring OCTN1 and OCTN2 expression in rats fed a high-fat diet. | [ |
| var | Hydroalcoholic extract from leaves | Clinical trial | Patients with metabolic syndrome | The administration of the | [ |
-, there is no data